• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G 蛋白偶联受体异源二聚体是物质使用障碍的关键参与者。

G protein-coupled receptor heteromers are key players in substance use disorder.

机构信息

Institut des Neurosciences Cellulaires et Integratives, UPR 3212, 5 rue Blaise Pascal, F-67000 Strasbourg, France.

Institut des Neurosciences Cellulaires et Integratives, UPR 3212, 5 rue Blaise Pascal, F-67000 Strasbourg, France.

出版信息

Neurosci Biobehav Rev. 2019 Nov;106:73-90. doi: 10.1016/j.neubiorev.2018.09.026. Epub 2018 Sep 29.

DOI:10.1016/j.neubiorev.2018.09.026
PMID:30278192
Abstract

G protein-coupled receptors (GPCR) represent the largest family of membrane proteins in the human genome. Physical association between two different GPCRs is linked to functional interactions which generates a novel entity, called heteromer, with specific ligand binding and signaling properties. Heteromerization is increasingly recognized to take place in the mesocorticolimbic pathway and to contribute to various aspects related to substance use disorder. This review focuses on heteromers identified in brain areas relevant to drug addiction. We report changes at the molecular and cellular levels that establish specific functional impact and highlight behavioral outcome in preclinical models. Finally, we briefly discuss selective targeting of native heteromers as an innovative therapeutic option.

摘要

G 蛋白偶联受体(GPCR)是人类基因组中最大的膜蛋白家族。两种不同 GPCR 之间的物理关联与功能相互作用有关,产生了一种新的实体,称为异源二聚体,具有特定的配体结合和信号转导特性。异源二聚体化越来越被认为发生在中边缘通路中,并有助于与物质使用障碍相关的各个方面。本综述重点介绍了与药物成瘾相关的大脑区域中鉴定的异源二聚体。我们报告了在分子和细胞水平上的变化,这些变化确立了特定的功能影响,并强调了临床前模型中的行为结果。最后,我们简要讨论了作为一种创新治疗选择的天然异源二聚体的选择性靶向。

相似文献

1
G protein-coupled receptor heteromers are key players in substance use disorder.G 蛋白偶联受体异源二聚体是物质使用障碍的关键参与者。
Neurosci Biobehav Rev. 2019 Nov;106:73-90. doi: 10.1016/j.neubiorev.2018.09.026. Epub 2018 Sep 29.
2
Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.G蛋白偶联受体信号传导的革命:阿片受体异聚体作为新型治疗靶点:IUPHAR综述10
Br J Pharmacol. 2014 Sep;171(18):4155-76. doi: 10.1111/bph.12798.
3
Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.针对滥用药物的 G 蛋白偶联受体的疾病特异性异源二聚化。
Prog Mol Biol Transl Sci. 2013;117:207-65. doi: 10.1016/B978-0-12-386931-9.00009-X.
4
Functional relevance of μ-δ opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology.μ-δ 阿片受体异源二聚体的功能相关性:在新型信号转导中的作用及其对治疗药物成瘾的影响:来自于 μ-阿片受体药理学新概念专题研讨会。
Drug Alcohol Depend. 2012 Mar 1;121(3):167-72. doi: 10.1016/j.drugalcdep.2011.10.025. Epub 2011 Nov 23.
5
Arrestin recruitment and signaling by G protein-coupled receptor heteromers.G 蛋白偶联受体异源二聚体的 arrestin 募集和信号转导。
Neuropharmacology. 2019 Jul 1;152:15-21. doi: 10.1016/j.neuropharm.2018.11.010. Epub 2018 Nov 9.
6
Understanding the role of heteroreceptor complexes in the central nervous system.了解异受体复合物在中枢神经系统中的作用。
Curr Protein Pept Sci. 2014;15(7):647. doi: 10.2174/138920371507140916122738.
7
Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.腹侧被盖区的功能性μ-阿片-甘丙肽受体异聚体
J Neurosci. 2017 Feb 1;37(5):1176-1186. doi: 10.1523/JNEUROSCI.2442-16.2016. Epub 2016 Dec 22.
8
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum.CB1 和 GPR55 受体在大鼠和猴子纹状体中共表达,并形成异源二聚体。
Exp Neurol. 2014 Nov;261:44-52. doi: 10.1016/j.expneurol.2014.06.017. Epub 2014 Jun 23.
9
Oligomerization of GPCRs involved in endocrine regulation.参与内分泌调节的G蛋白偶联受体的寡聚化。
J Mol Endocrinol. 2016 Jul;57(1):R59-80. doi: 10.1530/JME-16-0049. Epub 2016 May 5.
10
Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D₁-D₃ receptor heteromer.G 蛋白偶联受体同型二聚体作为中枢神经系统疾病治疗靶点的黄金时期:多巴胺 D₁-D₃ 受体同型二聚体。
CNS Neurol Disord Drug Targets. 2010 Nov;9(5):596-600. doi: 10.2174/187152710793361603.

引用本文的文献

1
Regulation of Cannabinoid and Opioid Receptor Levels by Endogenous and Pharmacological Chaperones.内源性和药理学伴侣蛋白对大麻素和阿片受体水平的调节。
J Pharmacol Exp Ther. 2024 Oct 18;391(2):279-288. doi: 10.1124/jpet.124.002187.
2
Chronic early-life lead exposure sensitizes adolescent rats to cocaine: Role of the dopaminergic system.早年长期接触铅使青春期大鼠对可卡因敏感:多巴胺能系统的作用。
Front Mol Neurosci. 2022 Aug 24;15:946726. doi: 10.3389/fnmol.2022.946726. eCollection 2022.
3
Class A and C GPCR Dimers in Neurodegenerative Diseases.
A 类和 C 类 G 蛋白偶联受体二聚体在神经退行性疾病中的作用。
Curr Neuropharmacol. 2022;20(11):2081-2141. doi: 10.2174/1570159X20666220327221830.
4
Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D-Serotonin 5-HT Heteromers.一种新型聚合物纳米载体的研发,该载体专门用于在多巴胺 D - 血清素 5 - HT 异聚体处实现氯氮平的可控递送。
Polymers (Basel). 2021 Mar 24;13(7):1000. doi: 10.3390/polym13071000.
5
The Balance of MU-Opioid, Dopamine D2 and Adenosine A2A Heteroreceptor Complexes in the Ventral Striatal-Pallidal GABA Antireward Neurons May Have a Significant Role in Morphine and Cocaine Use Disorders.腹侧纹状体-苍白球γ-氨基丁酸抗奖赏神经元中μ-阿片受体、多巴胺D2受体和腺苷A2A异源受体复合物的平衡可能在吗啡和可卡因使用障碍中起重要作用。
Front Pharmacol. 2021 Mar 15;12:627032. doi: 10.3389/fphar.2021.627032. eCollection 2021.
6
β-Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use.β-arrestin 2(ARRB2)多态性与慢性海洛因使用的不良后果相关。
Am J Addict. 2021 Jul;30(4):351-357. doi: 10.1111/ajad.13150. Epub 2021 Mar 30.
7
Dopamine D1-D2 receptor heteromer expression in key brain regions of rat and higher species: Upregulation in rat striatum after cocaine administration.大鼠和更高种属脑区多巴胺 D1-D2 受体异源二聚体的表达:可卡因给药后大鼠纹状体的上调。
Neurobiol Dis. 2020 Sep;143:105017. doi: 10.1016/j.nbd.2020.105017. Epub 2020 Jul 14.
8
Glial gene networks associated with alcohol dependence.与酒精依赖相关的神经胶质基因网络。
Sci Rep. 2019 Jul 29;9(1):10949. doi: 10.1038/s41598-019-47454-4.